awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35574508-2B462CF8-45C8-48F6-8E85-445603874407
Q35574508-2B462CF8-45C8-48F6-8E85-445603874407
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35574508-2B462CF8-45C8-48F6-8E85-445603874407
Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study.
P2860
Q35574508-2B462CF8-45C8-48F6-8E85-445603874407
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35574508-2B462CF8-45C8-48F6-8E85-445603874407
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc72019c4ff8ee4bdbc9fc90b9910d6f0681b020
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.